Abstract : In rats given a subcutaneous injection of 0.5 mg of Cd/kg, 6 days/ week for 15 weeks, daily excretion of cadmium in the urine and feces was determined.
INTRODUCTION

Cadmium
is highly accumulative and is deposited mainly in the liver and kidneys1 Five male Sprague-Dawley rats weighing 200-250 g were housed individually in stainless steel metabolic cages. They were fed a commercial pelleted diet (CE-2, Japan CLEA Inc., Tokyo) and sterilized tap water ad libitum. 'The cadmium content of the diet was described previously?). These animals were given daily subcutaneous injections of CdCl2 (0.5 mg of Cd/kg, 6 days/week) as described previously7).
Urine and feces of the animals were collected for a period of 24 hr at the end of each week. The urine was immediately centrifuged at 3000 rpm for 10 min and precipitates were removed and analyzed for cadmium by atomic absorption spectrophotometry after digestion in the manner described previously7). The whole feces of each animal were also analyzed after digestion as described above.
Cadmium analysis of organs and metallothionein
Total cadmium of liver, kidneys, heart, lung, spleen and testes, and cadmium distribution among these organs were derived from the previously reported data on cadmium analysis7) in rats receiving the same dosage as that in the present experiment.
Metallothionein was separated from the liver and kidneys of the abovementioned cadmium-injected animals in the manner reported previously10), and the cadmium content of this protein was determined.
RESULTS
Cadmium excretion in urine and feces Total cadmium of the liver, kidneys, heart, lung, spleen and testes and its distribution among these organs is shown in Table 1 . The total cadmium content increased steadily until the 10th week (throughout stages I and II), but declined thereafter (stage III). Cadmium in the liver and kidneys accounted for nearly 90 and 10% of the total content, respectively. Increase and decrease in total cadmium were parallel to the changes in the cadmium content of both the liver and the kidneys.
Nearly 80% of hepatic and renal cadmium was recovered in metallothionein. Fig. 3 shows the changes in the concentration of metallothionein cadmium in the liver and kidneys after cadmium injection. The hepatic concentration of meatllothionein cadmium increased with cadmium exposure during stages I and II, but showed a sharp decline in stage III. The concentration of metallothionein cadmium Relationships between accumulation and excretion of cadmium Fig. 4 shows the relationships between the total cadmium of the organs and the daily excretion of cadmium in the urine or feces after cadmium injection. Different relationships were seen between the cadmium content and the urinary excretion in the different stages. However, a linear relationship was obtained between the cadmium content and fecal excretion of cadmium throughout all the stages. The toxicological significance of these stages is given in the introduction.
Cadmium excretion in the urine and feces showed different changing patterns at the different levels of cadmium toxicity (Fig. 1) . These results indicate that the significant increase in urinary cadmium in stage II was involved in the onset of renal dysfunction and the more marked increase in stage III arose from the combination of the reanl and hepatic damage. Fecal cadmium increased without any significant signs of renal damage, but was slightly more affected by hepatic damage.
These results reveal that cadmium excretion in urine, but not in the feces, is markedly affected by cadmium toxicity.
The results of this study demonstrate that the relationship between the accumulation and urinary excretion of cadmium is affected by cadmium toxicity (Fig. 4) . Urinary cadmium was proportional to the body burden only beforc renal damage occurred, and exceeded fecal cadmium after the occurrence of both renal and hepatic damage. From the observation by Nomiyama and Nomiyama9) on rapidly decreased excretion of urinary cadmium after cessation of cadmium administration, it is probable that most of the increased urinary cadmium seen in stage III was due to the daily exposure to the element.
The feces were the main route of cadmium excretion for the first several weeks of cadmium administration (Fig. 2) . The same observation has been reported by Shaikh and Hirayama5). In our results, the increase in fecal cadmium was only a slight reflection of hepatic damage, but a linear relationship can be seen between the accumulation and fecal excretion of cadmium throughout all the stages (Fig. 4) . Nordberg11) demonstrated that fecal excretion of cadmium is related partly to the body burden and partly to the daily cadmium exposure. Our results strongly suggest that the relationship between the fecal excretion and the body burden or the daily exposure is scarcely affected by cadmium toxicity.
The decline in hepatic cadmium seen after the 12th week (Table 1 ) was accompanied by a rapid decrease in hepatic cadmium-thionein (Fig. 3) . At the same time increased plasma concentrations of cadmium-thionein were observed12). Urinary excretion of metallothionein increases after cadmium exposure13,14). This protein contains most of the urinary cadmium after cadmium toxicity appears3,5,151. It can be considered that the sharp increase in urinary cadmium seen in stage III may be a direct reflection of increased plasma levels of cadmium-thionein released from the injured hepatic cells.
One of the most striking findings in this study is the difference between the changing patterns of cadmium excretion in the urine and the feces in stage III as shown in Fig. 1 . The reason for this difference may be that hepatic metallothionein is released from the injured cells mainly into the blood, but hardly at all into the bile, or that if is released into the bile, the released cadmium-thionein may be easily reabsorbed in the intestines. AND 
